CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,290,842 | +13.9% | 120,787 | -9.4% | 0.00% | 0.0% |
| Q2 2023 | $2,888,383 | 0.0% | 133,351 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,888,383 | +9.5% | 133,351 | +2.7% | 0.00% | 0.0% |
| Q4 2022 | $2,638,351 | -99.9% | 129,904 | -2.3% | 0.00% | -50.0% |
| Q3 2022 | $3,409,119,000 | -12.6% | 132,961 | -18.9% | 0.00% | 0.0% |
| Q2 2022 | $3,898,683,000 | +2.9% | 163,948 | -2.5% | 0.00% | 0.0% |
| Q1 2022 | $3,788,157,000 | +27.9% | 168,213 | +12.4% | 0.00% | +100.0% |
| Q4 2021 | $2,962,040,000 | +1.6% | 149,598 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $2,914,372,000 | -3.9% | 148,088 | +7.4% | 0.00% | 0.0% |
| Q2 2021 | $3,032,370,000 | -3.9% | 137,835 | +4.0% | 0.00% | 0.0% |
| Q1 2021 | $3,154,435,000 | -15.3% | 132,595 | -6.8% | 0.00% | -50.0% |
| Q4 2020 | $3,722,176,000 | +95.8% | 142,285 | +30.3% | 0.00% | +100.0% |
| Q3 2020 | $1,900,992,000 | +2.6% | 109,221 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $1,852,758,000 | +47.5% | 110,152 | +4.3% | 0.00% | 0.0% |
| Q1 2020 | $1,256,226,000 | +31.5% | 105,654 | +33.9% | 0.00% | 0.0% |
| Q4 2019 | $954,944,000 | -30.8% | 78,921 | -19.2% | 0.00% | 0.0% |
| Q3 2019 | $1,380,481,000 | +68.9% | 97,664 | +33.2% | 0.00% | 0.0% |
| Q2 2019 | $817,295,000 | -23.4% | 73,300 | -19.3% | 0.00% | 0.0% |
| Q1 2019 | $1,066,591,000 | +0.3% | 90,851 | +14.1% | 0.00% | 0.0% |
| Q4 2018 | $1,063,550,000 | +12.4% | 79,607 | +17.9% | 0.00% | 0.0% |
| Q3 2018 | $946,463,000 | -7.5% | 67,508 | +3.7% | 0.00% | 0.0% |
| Q2 2018 | $1,022,964,000 | -3.0% | 65,074 | +1.5% | 0.00% | 0.0% |
| Q1 2018 | $1,054,429,000 | +2.0% | 64,099 | +12.0% | 0.00% | 0.0% |
| Q4 2017 | $1,033,916,000 | +35.0% | 57,249 | +44.3% | 0.00% | 0.0% |
| Q3 2017 | $765,882,000 | +68.7% | 39,683 | +3.1% | 0.00% | – |
| Q2 2017 | $454,016,000 | -10.4% | 38,476 | -16.7% | 0.00% | -100.0% |
| Q1 2017 | $506,538,000 | +422015.0% | 46,217 | +178.6% | 0.00% | – |
| Q4 2016 | $120,000 | -53.1% | 16,588 | -57.9% | 0.00% | – |
| Q3 2016 | $256,000 | +19.1% | 39,388 | 0.0% | 0.00% | – |
| Q2 2016 | $215,000 | +16.8% | 39,388 | 0.0% | 0.00% | – |
| Q1 2016 | $184,000 | +6.4% | 39,388 | +13.5% | 0.00% | – |
| Q4 2015 | $173,000 | +33.1% | 34,700 | 0.0% | 0.00% | – |
| Q3 2015 | $130,000 | -37.8% | 34,700 | 0.0% | 0.00% | – |
| Q2 2015 | $209,000 | +140.2% | 34,700 | -36.7% | 0.00% | – |
| Q3 2013 | $87,000 | -8.4% | 54,800 | 0.0% | 0.00% | – |
| Q2 2013 | $95,000 | – | 54,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |